IMRX

Immuneering Corp

Healthcare · Biotechnology

$177.14 sample

-1.22 (-0.68%) 1D

Market cap

$454.2B

Price as of

2026-10-15

Latest filing

8-K

Alerts

8

Price$177.14 +12.36% 3M daily closessample

178.38157.04

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08INSInsider buy: EVP, Operations
Oct 05INSInsider sell: Chief Executive Officer
Sep 29INSInsider buy: EVP, Operations
Sep 24INSInsider sell: Chief Executive Officer
Sep 18INSInsider sell: Chief Financial Officer
Sep 14INSInsider sell: Chief Executive Officer
Sep 07INSInsider buy: EVP, Operations
Sep 01INSInsider buy: Director

Sign up to see the real IMRX record →

Company facts

SEC EDGAR registration

Name: Immuneering Corp
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -36sample, -100 to +100
Reporting currency: USD

Who is positioning in IMRX

sample

Insiders: 10 insider transactions over 90 days, net selling, $97.9M
Congress: 5 members traded over 90 days
Institutions · 13F: 9 funds hold $4.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$18.8B +15.3% y/y

Q4 2024Q3 2026

Inventory$11.0B +8.2% y/y

Q4 2024Q3 2026

Accounts receivable$8.0B +4.2% y/y

Q4 2024Q3 2026

Total debt$21.1B +6.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $72.7B -8.9% 3M
Sample peer B: $267.3B +0.3% 3M
Sample peer C: $373.7B +0.6% 3M
Sample peer D: $402.5B +10.0% 3M
Sample peer E: $441.4B -11.3% 3M